Search - tctmd.com

Displaying 141 - 160 of 654

Sort: Relevancy | Date

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TCT 2020

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

Presenter: Rebecca T. Hahn

October 17, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

Presentation TCT 2020

TCT 474: Incidence and Impact of Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry

Presenter: julien ternacle

October 14, 2020

Presentation TCT 2020

TCT 128: Impact of Time-of-Day of Surgical or Transcatheter Aortic Valve Replacement Procedure on Outcomes: A Propensity-Score Matched Analysis From PARTNER Trials

Presenter: Flavien Vincent

October 14, 2020

Presentation TVT 2020

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Presenter: Susheel K. Kodali

June 21, 2020

Presentation Cardiovascular Interventions 2019

Show me the Data: Key Clinical Trials of 2019

Presenter: Ehtisham Mahmud

November 01, 2019

Presentation TCT 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

PARTNER 2 Trial and Registry: Impact of Left And Right Ventricular Longitudinal Systolic Strain Following Transcatheter and Surgical Aortic Valve Replacement

Presenter: Philippe Pibarot

September 28, 2019

Presentation TCT 2019

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Vinod Thourani

September 28, 2019

Presentation TCT 2019

TCT 2: Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement in Moderate Risk Patients: A Pooled PARTNER 2 Trial and Registry Study

Presenter: Katherine Chau

September 28, 2019

Presentation TCT 2019

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Presenter: Raj Makkar

September 27, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the PARTNER 3 Trial

Presenter: Martin Leon

September 26, 2019

Presentation TCT 2019

My Worst Complication of the Year

Presenter: Peter Soukas

September 25, 2019

Presentation TCT 2019

My Toughest Alternative Access Case of the Year

Presenter: Robert Lookstein

September 25, 2019

Presentation TCT 2019

My Toughest CLI Case of the Year

Presenter: Rahul Patel

September 25, 2019

Presentation TCT 2019

My Toughest Hybrid Case of the Year

Presenter: Bryan Fisher

September 25, 2019

Presentation TCT 2019

My Toughest BTK Case of the Year

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

My Toughest SFA Case of the Year

Presenter: Subhash Banerjee

September 25, 2019

Presentation TCT 2019

Debate: Atherectomy in Noncalcified Lesions Does Not Improve Outcomes!

Presenter: Christopher J White

September 25, 2019

Advertisement

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Five-Year Follow-Up from the PARTNER 2 Aortic Valve-in-Valve Registries: Clinical Outcomes, Valve Function, and Durability

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

TCT 474: Incidence and Impact of Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry

TCT 128: Impact of Time-of-Day of Surgical or Transcatheter Aortic Valve Replacement Procedure on Outcomes: A Propensity-Score Matched Analysis From PARTNER Trials

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Show me the Data: Key Clinical Trials of 2019

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

PARTNER 2 Trial and Registry: Impact of Left And Right Ventricular Longitudinal Systolic Strain Following Transcatheter and Surgical Aortic Valve Replacement

PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

TCT 2: Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement in Moderate Risk Patients: A Pooled PARTNER 2 Trial and Registry Study

PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Deep-Dive: NEW Insights From the PARTNER 3 Trial

My Worst Complication of the Year

My Toughest Alternative Access Case of the Year

My Toughest CLI Case of the Year

My Toughest Hybrid Case of the Year

My Toughest BTK Case of the Year

My Toughest SFA Case of the Year

Debate: Atherectomy in Noncalcified Lesions Does Not Improve Outcomes!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content